Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Waran Seri I Isra Presisi Indonesia Tbk. (ISAP-W) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Waran Seri I Isra Presisi Indonesia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Waran Seri I Isra Presisi Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Waran Seri I Isra Presisi Indonesia Tbk. trades at Rp13 (market cap 10.5B, 9.71M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 54.9× Waran Seri I Isra Presisi Indonesia Tbk.'s market cap, and Waran Seri I Isra Presisi Indonesia Tbk. is more actively traded (9.71M versus 3.48M). Which is the better fit depends on your goals.

ISAP-WLABS
Market Cap
10.5B576.7B
Volume
9.71M3.48M
Lot
97.14K34.82K
Turnover
125.85M522.79M
Average Price
12.96150.13
Value
125.85M522.79M
Indicative Equilibrium Price
13148
Indicative Equilibrium Volume
1K350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details

About Waran Seri I Isra Presisi Indonesia Tbk.

PT Isra Presisi Indonesia Tbk ("The Company") was established on October 22, 2011 based on Notary Deed No. 47 of Evi Nursamsiyati, S.H. The Company started its commercial operations in2011.

Read more on ISAP-W

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS